Dr. Markus Glatzer
Department of Radiation Oncology · Dept. IV
Exploring Capabilities of Large Language Models such as ChatGPT in Radiation Oncology.
Dennstädt F, Hastings J, Putora P, Vu E, Fischer G, Süveg K, Glatzer M, Riggenbach E, Hà H, Cihoric N. Exploring Capabilities of Large Language Models such as ChatGPT in Radiation Oncology. Adv Radiat Oncol 2023; 9:101400.
Nov 4, 2023Exploring Capabilities of Large Language Models such as ChatGPT in Radiation Oncology.
Nov 4, 2023Adv Radiat Oncol 2023; 9:101400
Dennstädt Fabio, Hastings Janna, Putora Paul Martin, Vu Erwin, Fischer Galina, Süveg Krisztian, Glatzer Markus, Riggenbach Elena, Hà Hông-Linh, Cihoric Nikola
In Reply to Raaijmakers et al.
Dennstädt F, Glatzer M, Medová M, Putora P. In Reply to Raaijmakers et al. Int J Radiat Oncol Biol Phys 2023; 115:1005.
Mar 15, 2023In Reply to Raaijmakers et al.
Mar 15, 2023Int J Radiat Oncol Biol Phys 2023; 115:1005
Dennstädt Fabio, Glatzer Markus, Medová Michaela, Putora Paul Martin
A precise and simple isodose-volume-based verification method for HDR and LDR brachytherapy plans.
Schiefer H, Heinze S, Glatzer M. A precise and simple isodose-volume-based verification method for HDR and LDR brachytherapy plans. Brachytherapy 2023; 22:400-406.
Jan 10, 2023A precise and simple isodose-volume-based verification method for HDR and LDR brachytherapy plans.
Jan 10, 2023Brachytherapy 2023; 22:400-406
Schiefer H, Heinze Simon, Glatzer Markus
Parameters of the Lyman Model for Calculation of Normal-Tissue Complication Probability: A Systematic Literature Review.
Dennstädt F, Medová M, Putora P, Glatzer M. Parameters of the Lyman Model for Calculation of Normal-Tissue Complication Probability: A Systematic Literature Review. Int J Radiat Oncol Biol Phys 2022; 115:696-706.
Aug 24, 2022Parameters of the Lyman Model for Calculation of Normal-Tissue Complication Probability: A Systematic Literature Review.
Aug 24, 2022Int J Radiat Oncol Biol Phys 2022; 115:696-706
Dennstädt Fabio, Medová Michaela, Putora Paul Martin, Glatzer Markus
Role of Brachytherapy in the Postoperative Management of Endometrial Cancer: Decision-Making Analysis among Experienced European Radiation Oncologists.
Glatzer M, Petric P, van der Steen-Banasik E, Lössl K, Jürgenliemk-Schulz I, Niehoff P, Hermansson R, Nout R, Putora P, Plasswilm L, Nakken E, Cooper R, Tanderup K, Rovirosa A, Fokdal L, Ordeanu C, Tagliaferri L, Chargari C, Strnad V, Dimopoulos J, Šegedin B, Tselis N. Role of Brachytherapy in the Postoperative Management of Endometrial Cancer: Decision-Making Analysis among Experienced European Radiation Oncologists. Cancers (Basel) 2022; 14
Feb 11, 2022Role of Brachytherapy in the Postoperative Management of Endometrial Cancer: Decision-Making Analysis among Experienced European Radiation Oncologists.
Feb 11, 2022Cancers (Basel) 2022; 14
Glatzer Markus, Petric Primoz, van der Steen-Banasik Elzbieta, Lössl Kristina, Jürgenliemk-Schulz Ina M, Niehoff Peter, Hermansson Ruth S, Nout Remi A, Putora Paul Martin, Plasswilm Ludwig, Nakken Esten Søndrol, Cooper Rachel, Tanderup Kari, Rovirosa Angeles, Fokdal Lars, Ordeanu Claudia, Tagliaferri Luca, Chargari Cyrus, Strnad Vratislav, Dimopoulos Johannes Athanasios, Šegedin Barbara, Tselis Nikolaos
Radioimmunotherapy: future prospects from the perspective of brachytherapy
Fleischmann M, Glatzer M, Rödel C, Tselis N. Radioimmunotherapy: future prospects from the perspective of brachytherapy. J Contemp Brachytherapy 2021; 13:458-467.
Aug 24, 2021Radioimmunotherapy: future prospects from the perspective of brachytherapy
Aug 24, 2021J Contemp Brachytherapy 2021; 13:458-467
Fleischmann Maximilian, Glatzer Markus, Rödel Claus, Tselis Nikolaos
Role of Postoperative Radiotherapy in the Management for Resected NSCLC - Decision Criteria in Clinical Routine Pre- and Post-LungART
Süveg K, McDonald F, Dziadziuszko R, Belderbos J, Ricardi U, Manapov F, Lievens Y, Geets X, Dieckmann K, Guckenberger M, Andratschke N, Nestle U, Peeters S, Le Pechoux C, Faivre-Finn C, Putora P, De Ruysscher D, Widder J, Van Houtte P, Troost E, Slotman B, Ramella S, Pöttgen C, Glatzer M. Role of Postoperative Radiotherapy in the Management for Resected NSCLC - Decision Criteria in Clinical Routine Pre- and Post-LungART. Clin Lung Cancer 2021; 22:579-586.
Aug 14, 2021Role of Postoperative Radiotherapy in the Management for Resected NSCLC - Decision Criteria in Clinical Routine Pre- and Post-LungART
Aug 14, 2021Clin Lung Cancer 2021; 22:579-586
Süveg Krisztian, McDonald Fiona, Dziadziuszko Rafal, Belderbos Jose, Ricardi Umberto, Manapov Farkhad, Lievens Yolande, Geets Xavier, Dieckmann Karin, Guckenberger Matthias, Andratschke Nicolaus, Nestle Ursula, Peeters Stephanie T H, Le Pechoux Cecile, Faivre-Finn Corinne, Putora Paul Martin, De Ruysscher Dirk, Widder Joachim, Van Houtte Paul, Troost Esther G C, Slotman Ben J, Ramella Sara, Pöttgen Christoph, Glatzer Markus
Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists
Glatzer M, Kocher G, Kraxner P, Krueger T, Martucci F, Oehler C, Ozsahin M, Papachristofilou A, Wagnetz D, Zaugg K, Zwahlen D, Opitz I, Kestenholz P, Karenovics W, Leskow P, Caparrotti F, Elicin O, Furrer M, Gambazzi F, Dutly A, Gelpke H, Guckenberger M, Heuberger J, Inderbitzi R, Cafarotti S, Putora P. Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists. Transl Lung Cancer Res 2021; 10:1960-1968.
Apr 1, 2021Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists
Apr 1, 2021Transl Lung Cancer Res 2021; 10:1960-1968
Glatzer Markus, Kocher Gregor Jan, Kraxner Peter, Krueger Thorsten, Martucci Francesco, Oehler Christoph, Ozsahin Mahmut, Papachristofilou Alexandros, Wagnetz Dirk, Zaugg Kathrin, Zwahlen Daniel, Opitz Isabelle, Kestenholz Peter, Karenovics Wolfram, Leskow Pawel, Caparrotti Francesca, Elicin Olgun, Furrer Markus, Gambazzi Franco, Dutly André, Gelpke Hans, Guckenberger Matthias, Heuberger Jürg, Inderbitzi Rolf, Cafarotti Stefano, Putora Paul Martin
Radiotherapy for thymic epithelial tumours: a review
Süveg K, Putora P, Jörger M, Iseli T, Fischer G, Ammann K, Glatzer M. Radiotherapy for thymic epithelial tumours: a review. Transl Lung Cancer Res 2021; 10:2088-2100.
Apr 1, 2021Radiotherapy for thymic epithelial tumours: a review
Apr 1, 2021Transl Lung Cancer Res 2021; 10:2088-2100
Süveg Krisztian, Putora Paul Martin, Jörger Markus, Iseli Thomas, Fischer Galina Farina, Ammann Karlheinz, Glatzer Markus
Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the 'TOaSTT' database
Kroeze S, Eckert F, Lohaus F, Sackerer I, Skazikis G, Geier M, Szuecs M, Glatzer M, Schymalla M, Adebahr S, Verhoeff J, Siva S, Roeder F, Kahl K, Blanck O, Kaul D, Fritz C, Schaule J, Guckenberger M. Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the 'TOaSTT' database. Radiat Oncol 2021; 16:4.
Jan 6, 2021Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the 'TOaSTT' database
Jan 6, 2021Radiat Oncol 2021; 16:4
Kroeze Stephanie G C, Eckert Franziska, Lohaus Fabian, Sackerer Irina, Skazikis Georgios, Geier Michael, Szuecs Marcella, Glatzer Markus, Schymalla Markus M, Adebahr Sonja, Verhoeff Joost J C, Siva Shankar, Roeder Falk, Kahl Klaus H, Blanck Oliver, Kaul David, Fritz Corinna, Schaule Jana, Guckenberger Matthias
Role of radiotherapy in the management of brain metastases of NSCLC - Decision criteria in clinical routine
Glatzer M, Dziadziuszko R, Belderbos J, Ricardi U, Manapov F, Lievens Y, Geets X, Dieckmann K, Guckenberger M, Andratschke N, Süveg K, Le Pechoux C, McDonald F, Faivre-Finn C, De Ruysscher D, Widder J, Van Houtte P, Troost E, Slotman B, Ramella S, Pöttgen C, Peeters S, Nestle U, Putora P. Role of radiotherapy in the management of brain metastases of NSCLC - Decision criteria in clinical routine. Radiother Oncol 2020; 154:269-273.
Nov 11, 2020Role of radiotherapy in the management of brain metastases of NSCLC - Decision criteria in clinical routine
Nov 11, 2020Radiother Oncol 2020; 154:269-273
Glatzer Markus, Dziadziuszko Rafal, Belderbos Jose, Ricardi Umberto, Manapov Farkhad, Lievens Yolande, Geets Xavier, Dieckmann Karin, Guckenberger Matthias, Andratschke Nicolaus, Süveg Krisztian, Le Pechoux Cecile, McDonald Fiona, Faivre-Finn Corinne, De Ruysscher Dirk, Widder Joachim, Van Houtte Paul, Troost Esther G C, Slotman Ben J, Ramella Sara, Pöttgen Christoph, Peeters Stephanie T H, Nestle Ursula, Putora Paul Martin
Adverse events reporting in stage III NSCLC trials investigating surgery and radiotherapy
Iseli T, Berghmans T, Glatzer M, Rittmeyer A, Massard G, Durieux V, Buchsbaum T, Putora P. Adverse events reporting in stage III NSCLC trials investigating surgery and radiotherapy. ERJ Open Res 2020; 6
Sep 14, 2020Adverse events reporting in stage III NSCLC trials investigating surgery and radiotherapy
Sep 14, 2020ERJ Open Res 2020; 6
Iseli Thomas, Berghmans Thierry, Glatzer Markus, Rittmeyer Achim, Massard Gilbert, Durieux Valérie, Buchsbaum Thomas, Putora Paul Martin
Decision-Making Analysis for Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: A Survey by the Executive Committee of the Peritoneal Surface Oncology Group International (PSOGI)
Steffen T, Yutaka Y, Paul S, Beate R, Quadros C, Pompiliu P, Morris D, Moran B, Yan L, Ignace d, Goere D, Glehen O, Glatzer M, Lana B, Häller L, Putora P. Decision-Making Analysis for Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: A Survey by the Executive Committee of the Peritoneal Surface Oncology Group International (PSOGI). Oncology 2020; 99:41-48.
Sep 11, 2020Decision-Making Analysis for Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: A Survey by the Executive Committee of the Peritoneal Surface Oncology Group International (PSOGI)
Sep 11, 2020Oncology 2020; 99:41-48
Steffen Thomas, Yutaka Yonemura, Paul Sugarbaker, Beate Rau, Quadros Claudio A, Pompiliu Piso, Morris David L, Moran Brendan J, Yan Li, Ignace de Hingh, Goere Diane, Glehen Olivier, Glatzer Markus, Lana Bijelic, Häller Lukas, Putora Paul Martin
Patient Selection for Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Cancer: Consensus on Decision Making Among International Experts
Steffen T, Yutaka Y, Paul S, Beate R, Claudio Q, Pompiliu P, David M, Brandon M, Yan L, Ignace d, Goere D, Glehen O, Glatzer M, Lana B, Eden J, Martin P. Patient Selection for Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Cancer: Consensus on Decision Making Among International Experts. Clin Colorectal Cancer 2020; 19:277-284.
Jul 15, 2020Patient Selection for Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Cancer: Consensus on Decision Making Among International Experts
Jul 15, 2020Clin Colorectal Cancer 2020; 19:277-284
Steffen Thomas, Yutaka Yonemura, Paul Sugarbaker, Beate Rau, Claudio Quadros, Pompiliu Piso, David Morris, Brandon Moran, Yan Li, Ignace de Hingh, Goere Diane, Glehen Olivier, Glatzer Markus, Lana Bijelic, Eden Janina, Martin Putora Paul
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
Opitz I, Greillier L, Hoda M, Klepetko W, Lacourt A, McElnay P, Maskell N, Mutti L, Pairon J, Van Schil P, van Meerbeeck J, Waller D, Weder W, Putora P, Galateau-Salle F, Fennell D, Scherpereel A, Berghmans T, Psallidas I, Glatzer M, Rigau D, Astoul P, Bölükbas S, Boyd J, Coolen J, De Bondt C, De Ruysscher D, Durieux V, Faivre-Finn C, Cardillo G. ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2020; 58:1-24.
Jul 1, 2020ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
Jul 1, 2020Eur J Cardiothorac Surg. 2020; 58:1-24
Opitz Isabelle, Greillier Laurent, Hoda Mir Ali, Klepetko Walter, Lacourt Aude, McElnay Phil, Maskell Nick A, Mutti Luciano, Pairon Jean-Claude, Van Schil Paul, van Meerbeeck Jan P, Waller David, Weder Walter, Putora Paul Martin, Galateau-Salle Francoise, Fennell Dean A, Scherpereel Arnaud, Berghmans Thierry, Psallidas Ioannis, Glatzer Markus, Rigau David, Astoul Philippe, Bölükbas Servet, Boyd Jeanette, Coolen Johan, De Bondt Charlotte, De Ruysscher Dirk, Durieux Valérie, Faivre-Finn Corinne, Cardillo Giuseppe
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
Scherpereel A, Greillier L, Hoda M, Klepetko W, Lacourt A, McElnay P, Maskell N, Mutti L, Pairon J, Van Schil P, van Meerbeeck J, Waller D, Weder W, Cardillo G, Galateau-Salle F, Fennell D, Opitz I, Berghmans T, Psallidas I, Glatzer M, Rigau D, Astoul P, Bölükbas S, Boyd J, Coolen J, De Bondt C, De Ruysscher D, Durieux V, Faivre-Finn C, Putora P. ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma. Eur Respir J. 2020; 55
Jun 11, 2020ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
Jun 11, 2020Eur Respir J. 2020; 55
Scherpereel Arnaud, Greillier Laurent, Hoda Mir Ali, Klepetko Walter, Lacourt Aude, McElnay Phil, Maskell Nick A, Mutti Luciano, Pairon Jean-Claude, Van Schil Paul, van Meerbeeck Jan P, Waller David, Weder Walter, Cardillo Giuseppe, Galateau-Salle Francoise, Fennell Dean, Opitz Isabelle, Berghmans Thierry, Psallidas Ioannis, Glatzer Markus, Rigau David, Astoul Philippe, Bölükbas Servet, Boyd Jeanette, Coolen Johan, De Bondt Charlotte, De Ruysscher Dirk, Durieux Valérie, Faivre-Finn Corinne, Putora Paul Martin
Once daily versus twice-daily radiotherapy in the management of limited disease small cell lung cancer - Decision criteria in routine practise
Glatzer M, Belderbos J, Dziadziuszko R, Le Pechoux C, McDonald F, Nestle U, Peeters S, Pöttgen C, Ramella S, Slotman B, Dahele M, Troost E, Van Houtte P, Widder J, De Ruysscher D, Faivre-Finn C, Putora P. Once daily versus twice-daily radiotherapy in the management of limited disease small cell lung cancer - Decision criteria in routine practise. Radiother Oncol 2020; 150:26-29.
May 22, 2020Once daily versus twice-daily radiotherapy in the management of limited disease small cell lung cancer - Decision criteria in routine practise
May 22, 2020Radiother Oncol 2020; 150:26-29
Glatzer Markus, Belderbos Jose, Dziadziuszko Rafal, Le Pechoux Cecile, McDonald Fiona, Nestle Ursula, Peeters Stephanie T H, Pöttgen Christoph, Ramella Sara, Slotman Ben J, Dahele M R, Troost Esther G C, Van Houtte Paul, Widder Joachim, De Ruysscher Dirk, Faivre-Finn Corinne, Putora Paul Martin
Insular Decision Criteria in Clinical Practice: Analysis of Decision-Making in Oncology
Iseli T, Plasswilm L, Sirén C, Schmidt B, Rothermundt C, Hundsberger T, Glatzer M, Panje C, Fischer G, Putora P. Insular Decision Criteria in Clinical Practice: Analysis of Decision-Making in Oncology. Oncology 2020; 98:438-444.
May 19, 2020Insular Decision Criteria in Clinical Practice: Analysis of Decision-Making in Oncology
May 19, 2020Oncology 2020; 98:438-444
Iseli Thomas, Plasswilm Ludwig, Sirén Charlotta, Schmidt Barbara, Rothermundt Christian, Hundsberger Thomas, Glatzer Markus, Panje Cédric, Fischer Galina, Putora Paul Martin
Choice of first line systemic treatment in pancreatic cancer among national experts
Glatzer M, Pless M, Pederiva S, Pestalozzi B, Berger M, Inauen R, Winterhalder R, Montemurro M, Horber D, Putora P. Choice of first line systemic treatment in pancreatic cancer among national experts. Pancreatology 2020; 20 (2020):686-690.
Mar 31, 2020Choice of first line systemic treatment in pancreatic cancer among national experts
Mar 31, 2020Pancreatology 2020; 20 (2020):686-690
Glatzer Markus, Pless Miklos, Pederiva S., Pestalozzi Bernhard, Berger M.D., Inauen Roman, Winterhalder Ralf, Montemurro Michael, Horber Daniel, Putora Paul Martin
Choice of first line systemic treatment in pancreatic cancer among national experts
Glatzer M, Pless M, Pederiva S, Pestalozzi B, Berger M, Inauen R, Winterhalder R, Montemurro M, Horber D, Putora P. Choice of first line systemic treatment in pancreatic cancer among national experts. Pancreatology 2020; 20:686-690.
Mar 31, 2020Choice of first line systemic treatment in pancreatic cancer among national experts
Mar 31, 2020Pancreatology 2020; 20:686-690
Glatzer Markus, Pless M, Pederiva S, Pestalozzi B, Berger M D, Inauen R, Winterhalder R, Montemurro M, Horber D, Putora Paul Martin